Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to begin to collect information and to try to learn whether
or not cetuximab works in treating patients with unresectable or metastatic hepatocellular
carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Bristol-Myers Squibb Dana-Farber Cancer Institute